The Center for Pediatric Genomic Medicine at Children's Mercy was established in 2011. Among the first of its kind with a pediatric focus, the center provides clinical genomic services and is an epicenter for genomic research. Although our focus is sequencing and analysis of rare inherited diseases in children, plans are underway for expansion into a translational cancer genomics program and the use of pharmacogenomics in precision medicine.
Genomic Medicine Staff
Our staff includes MDs, PhDs, RNs and clinical laboratory scientists experienced in genome analysis. Team members feature board-certified clinical molecular geneticists, genetic counselors, bioinformaticians and software engineers. We work closely with the Center for Bioethics and collaborate with physicians representing every subspecialty at Children's Mercy.
Meet our team »
The Center has developed clinical tests for next-generation medical treatments designed to improve outcomes in patients at Children's Mercy and around the world. Learn more about whole genome sequencing (WGS) and targeted gene sequencing and custom analysis (TaGSCAN).
Children's Mercy is dedicated to becoming a leader in pediatric translational research — studies that translate medical research into better ways of treating sick kids. This commitment is leading to new breakthroughs in treating, diagnosing and preventing complex childhood diseases, which, in turn, transforms lives of kids in our community and around the world. Learn more about Stat-Seq
The Center performs genomic tests for internal and external investigators. One of these research tests is exome sequencing, which involves decoding the working regions of all 23,000 genes in the genome. The test is performed on patients with a disease that has been refractory to standing testing in order to identify novel diseases and disease genes.